|
N.A. Konyshko, T.E. Morozova.
Biometric predictors of kidney remodeling in pregnant women
|
№5 / 2014
|
|
N.A. Muhin, L.V. Kozlovskaya, V.V. Fomin, T.Yu. Stahova, M.V. Lebedeva, I.M. Balkarov
Renal damage in patients with arterial hypertension and hyperuricemia: personalised approach to prognosis
|
№4 / 2014
|
|
Z.R. Bashirova, E.S. Vozdvizhenskaya, I.M. Osmanov
The clinical value of the determination of matrix metalloproteinases and their inhibitors in children with autosomal dominant polycystic kidney disease
|
№2 / 2014
|
|
E.G. Ovskaya
Dynamics of osteopontin levels during therapy with candesartan in patients on program hemodialysis
|
№2 / 2014
|
|
M.Yu. Krupnova, M.V. Bondarenko, V.V. Marasaev
Chronic kidney disease: risk factors for development and progression
|
№5 / 2013
|
|
A.P. Rebrov, A.L. Kuklina
Renal dysfunction in patients with arterial hypertension in presense and absense of comorbid conditions
|
№5 / 2013
|
|
V.A., Zhmurov, D.V. Zhmurov, S.A. Oskolkov, V.G. Yarkova, D.E Kovalchuk., S.V. Artem'eva
Impact of direct renin inhibitor on central hemodynamics parameters and thrombocytes structure and function in patients with chronic kidney disease and arterial hypertension
|
№3 / 2013
|
|
G.P. Arutiunov, L.G. Oganezova, A.V. Sokolova
Health centers: opportunities and perspectives in early diagnosis of heart failure and kidney involvement in patients with arterial hypertension
|
№1 / 2012
|
|
G.P. Arutyunov, L.G. Oganezova, D.O. Dragunov, A.V. Sokolova
Arterial hypertension epidemiology: associations with renal involvement and salt-sensitivity phenomena
|
№2 / 2013
|
|
A.P. Rebrov, A.L. Kuklina
Cystatin C and target organ damage in arterial hypertension
|
№2 / 2013
|
|
Fomin V.V., Kupriyanov I.E., Razuvaeva M.A.
Multiple renal arteries – an epiphenomena or potential cause of arterial hypertension?
|
№5-6 / 2012
|
|
Rebrov A.P.,Kuklina A.L.
Renal function parameters and endothelial disfunction in patients with arterial hypertension
|
№5-6 / 2012
|
Русский
